Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jun 21, 2023 12:54pm
128 Views
Post# 35507477

RE:RE:RE:Why not SZLS?

RE:RE:RE:Why not SZLS?They have access to $25 Million.  $25 million is unheard of for such a small company. 

Use that to:

-market (radio, TV, social media, sponsorships, SEO, Google ads)
-give away free tests by using the cash to cover cost of goods,
-or drop the price of tests to $500 for the first year until you gain traction
-hire dozens of sales people,
-hire a marketing company,
-hire a VP Sales,
-hire a lobbying company to go after the partnerships, government health plans or insurance companies
-open pop up testing clinics in major cities with tons of noise,
-buy spots on Fox news, Bloomberg and get interviewed and get the word out,
-wine and dine health care groups. Give them a great intro price on tests.  

Exas operated at a huge loss but their revenue was excellent.  Use that apporach.  Take a chunk of the $25 million operate at a bigger loss but show some revenues.  This trying to slow play to cash positive isn't working.

Stage just leaves the GEM money sitting there and earns $1 million a quarter.  Just SMH.  The deal with GEM is 3 years what are you waiting for.

Fire the entire Board and Scientific Board.  Hire executives with key relationships who can market and sell with a track record or rolling out new products and getting sales.  Get a new CEO that is sales focused who understands you have to spend to gain market share.  Tap into the war chest and LETS GO!! 

DO SOMETHING FFS!!
<< Previous
Bullboard Posts
Next >>